+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Latent TB Testing Market (2023 Edition): Analysis By Test Type (TST, IGRA), End User, By Region, By Country: Market Insights and Forecast (2019-2029)

  • PDF Icon

    Report

  • 200 Pages
  • December 2023
  • Region: Global
  • Azoth Analytics
  • ID: 5912553
Description Jump to:
The publisher has released a research report titled “Global Latent TB Testing Market (2023 Edition)” which provides a complete analysis of the Global Latent TB Testing industry in terms of market segmentation By Test Type (Tuberculin Skin Test -TST, Interferon Gamma Released Assay -IGRA), By End User (Diagnostic Laboratories, Hospitals and Clinics, Academic and Research Institute), By Region (Americas , Europe, Asia-pacific, Middle-East & Africa), for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, China, Japan, India, South Korea, Australia). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Latent TB Testing Market is expected to generate USD 3.93 Billion by the end of 2029, up from USD 1.8 Billion in 2022. A favourable growth element for the global Latent TB Testing market is propelled by government initiatives and policies, raising awareness and education, and technological advancements in testing methods. During the forecast period, 2024-2029, Global Latent TB Testing is expected to expand at a CAGR of 12%. The prevalence of TB, especially in high-burden regions, drives the need for effective latent TB testing. As TB remains a global health concern, early detection and management of latent infections become critical for disease control.

According to the National Library of Medicine, “one-third” of the world's population, or roughly 2.3 billion people, have LTBI. The WHO estimates that approximately 2 billion people, or more than one-third of the global total, are TB carriers. A high prevalence of latent TB indicates a larger pool of individuals at risk of developing active TB. Latent TB testing becomes essential for identifying those with latent infections, allowing for early intervention and preventive measures.

Technological advancements contribute to the improvement of latent TB testing methods, making them more reliable, convenient, and suitable for diverse healthcare settings. Continued research and innovation in the field are expected to further enhance the accuracy and accessibility of latent TB testing in the future.

The development of next-generation interferon-gamma release assays (IGRAs), such as the QuantiFERON-TB Gold Plus, represents an improvement over earlier versions. These assays offer enhanced sensitivity and specificity in detecting latent TB infections, reducing the likelihood of false-positive results.

Quality assurance and standardization in diagnostic laboratories are gaining prominence. Adherence to international quality standards and the establishment of standardized testing protocols are essential for ensuring the reliability and comparability of latent TB test results. Laboratories are focusing on maintaining high-quality testing procedures. Ongoing R&D efforts lead to the development of improved testing technologies, such as next-generation assays and advanced molecular diagnostic methods. These technologies often offer enhanced sensitivity, specificity, and faster turnaround times, improving the overall efficiency of latent TB testing.

Scope of the Report

  • The report analyses the Latent TB Testing Market by Value (USD Million).
  • The report presents the analysis of Latent TB Testing Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
  • The report analyses the Latent TB Testing Market by Test Type (Tuberculin Skin Test -TST, Interferon Gamma Released Assay -IGRA).
  • The report analyses the Latent TB Testing Market by End User (Diagnostic Laboratories, Hospitals and Clinics, Academic and Research Institute).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include QIAGEN, Sanofi, Abbott Laboratories, Serum Institute of India, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, PerkinElmer Inc., BioMerieux, Becton Dickinson and Co, LIONEX GmbH.

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodolog
2. Strategic Recommendations
2.1 Amplify the incorporation of technological advancement in diagnostic laboratories
2.2 Increase the R&D spending to improve the efficacy of testing rates
3. Global Latent TB Testing Market: Historic and Forecast (2019-2029)
3.1 Impact Analysis of Macro Economic Factors on Global Latent TB Testing Market
3.2 Epidemiology: Global Latent TB Prevalence
3.3 Epidemiology: Global Tuberculosis Prevalence
3.4 Epidemiology: Global Tuberculosis Incidence
3.5 Global Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
3.6 Degree of Impact of Covid-19 on Latent TB Testing Market
3.7 Global Latent TB Testing Market Segmentation: By Test Type
3.7.1 Global Latent TB Testing Market, By Test Type Overview
3.7.2 Global Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
3.7.3 Global Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)
3.8 Global Latent TB Testing Market Segmentation: By End User
3.8.1 Global Latent TB Testing Market, By End User Overview
3.8.2 Global Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
3.8.3 Global Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
3.8.4 Global Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
4. Global Latent TB Testing Market, Regional Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Latent TB Testing Market: Historic and Forecast (2019-2029)
5.1 Americas Latent TB Testing Market: Snapshot
5.2 Americas Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.3 Americas Latent TB Testing Market: Key Factors
5.4 Americas Latent TB Testing Market: Segment Analysis
5.5 Americas Latent TB Testing Market Segmentation : By Test Type
5.5.1 Americas Latent TB Testing Market, By Test Type Overview
5.5.2 Americas Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
5.5.3 Americas Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)
5.6 Americas Latent TB Testing Market Segmentation : By End User
5.6.1 Americas Latent TB Testing Market, By End User Overview
5.6.2 Americas Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
5.6.3 Americas Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
5.6.4 Americas Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
5.7 Americas Latent TB Testing Market Segmentation: By Country
5.7.1 Americas Latent TB Testing Market, By Country Overview
5.7.2 United States Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.7.2.1 United States Latent TB Testing Market, By Test Type
5.7.2.2 United States Latent TB Testing Market, By End User
5.7.3 Canada Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.7.3.1 Canada Latent TB Testing Market, By Test Type
5.7.3.2 Canada Latent TB Testing Market, By End User
5.7.4 Rest of Americas Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.7.4.1 Rest of Americas Latent TB Testing Market, By Test Type
5.7.4.2 Rest of Americas Latent TB Testing Market, By End User
6. Europe Latent TB Testing Market: Historic and Forecast (2019-2029)
6.1 Europe Latent TB Testing Market: Snapshot
6.2 Europe Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.3 Europe Latent TB Testing Market: Key Factors
6.4 Europe Latent TB Testing Market: Segment Analysis
6.5 Europe Latent TB Testing Market Segmentation: By Test Type
6.5.1 Europe Latent TB Testing Market, By Test Type Overview
6.5.2 Europe Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
6.5.3 Europe Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)
6.6 Europe Latent TB Testing Market Segmentation: By End User
6.6.1 Europe Latent TB Testing Market, By End User Overview
6.6.2 Europe Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
6.6.3 Europe Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
6.6.4 Europe Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
6.7 Europe Latent TB Testing Market Segmentation: By Country
6.7.1 Europe Latent TB Testing Market, By Country Overview
6.7.2 Germany Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.7.2.1 Germany Latent TB Testing Market, By Test Type
6.7.2.2 Germany Latent TB Testing Market, By End User
6.7.3 United Kingdom Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.7.3.1 United Kingdom Latent TB Testing Market, By Test Type
6.7.3.2 United Kingdom Latent TB Testing Market, By End User
6.7.4 France Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.7.4.1 France Latent TB Testing Market, By Test Type
6.7.4.2 France Latent TB Testing Market, By End User
6.7.5 Rest of Europe Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.7.5.1 Rest of Europe Latent TB Testing Market, By Test Type
6.7.5.2 Rest of Europe Latent TB Testing Market, By End User
7. Asia Pacific Latent TB Testing Market: Historic and Forecast (2019-2029)
7.1 Asia Pacific Latent TB Testing Market: Snapshot
7.2 Asia Pacific Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.3 Asia Pacific Latent TB Testing Market: Key Factors
7.4 Asia Pacific Latent TB Testing Market: Segment Analysis
7.5 Asia Pacific Latent TB Testing Market Segmentation: By Test Type
7.5.1 Asia Pacific Latent TB Testing Market, By Test Type Overview
7.5.2 Asia Pacific Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
7.5.3 Asia Pacific Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)
7.6 Asia Pacific Latent TB Testing Market Segmentation: By End User
7.6.1 Asia Pacific Latent TB Testing Market, By End User Overview
7.6.2 Asia Pacific Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
7.6.3 Asia Pacific Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
7.6.4 Asia Pacific Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
7.7 Asia Pacific Latent TB Testing Market Segmentation: By Country
7.7.1 Asia Pacific Latent TB Testing Market, By Country Overview
7.7.2 China Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.2.1 China Latent TB Testing Market, By Test Type
7.7.2.2 China Latent TB Testing Market, By End User
7.7.3 Japan Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.3.1 Japan Latent TB Testing Market, By Test Type
7.7.3.2 Japan Latent TB Testing Market, By End User
7.7.4 India Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.4.1 India Latent TB Testing Market, By Test Type
7.7.4.2 India Latent TB Testing Market, By End User
7.7.5 South Korea Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.5.1 South Korea Latent TB Testing Market, By Test Type
7.7.5.2 South Korea Latent TB Testing Market, By End User
7.7.6 Australia Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.6.1 Australia Latent TB Testing Market, By Test Type
7.7.6.2 Australia Latent TB Testing Market, By End User
7.7.7 Rest of Asia Pacific Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.7.1 Rest of Asia Pacific Latent TB Testing Market, By Test Type
7.7.7.2 Rest of Asia Pacific Latent TB Testing Market, By End User
8. Middle East & Africa Latent TB Testing Market: Historic and Forecast (2019-2029)
8.1 Middle East and Africa Latent TB Testing Market: Snapshot
8.2 Middle East and Africa Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
8.3 Middle East and Africa Latent TB Testing Market: Key Factors
8.4 Middle East and Africa Latent TB Testing Market: Segment Analysis
8.5 Middle East and Africa Latent TB Testing Market Segmentation : By Test Type
8.5.1 Middle East and Africa Latent TB Testing Market, By Test Type Overview
8.5.2 Middle East and Africa Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
8.5.3 Middle East and Africa Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)
8.6 Middle East and Africa Latent TB Testing Market Segmentation : By End User
8.6.1 Middle East and Africa Latent TB Testing Market, By End User Overview
8.6.2 Middle East and Africa Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
8.6.3 Middle East and Africa Latent TB Testing Market, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
8.6.4 Middle East and Africa Latent TB Testing Market, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Global Latent TB Testing Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Landscape
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Latent TB testing Market
11.4 Company Profiling
11.4.1 QIAGEN
11.4.2 Sanofi
11.4.3 Abbott Laboratories
11.4.4 F. Hoffmann-La Roche AG
11.4.5 Bio-Rad Laboratories
11.4.6 BioMerieux
11.4.7 Becton Dickinson and Co
11.4.8 Serum Institute of India
11.4.9 PerkinElmer Inc.
11.4.10 LIONEX GmbH
List of Figures
Figure 1: Global Latent TB Testing Market Size, By Value, 2019-2022 (USD Million)
Figure 2: Global Latent TB Testing Market Size, By Value, 2023-2029 (USD Million)
Figure 3: Global Latent TB Testing Market Share, By Test Type, 2022 (%)
Figure 4: Global Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
Figure 5: Global Latent TB Testing Market Absolute Opportunity, By Tuberculin Skin Test (TST), 2019H-2029F (USD Million)
Figure 6: Global Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA) , By Value, 2019H-2029F (USD Million & CAGR)
Figure 7: Global Latent TB Testing Market Absolute Opportunity, By Interferon Gamma Released Assay (IGRA) , 2019H-2029F (USD Million)
Figure 8: Global Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
Figure 9: Global Latent TB Testing Market Absolute Opportunity, By Diagnostic Laboratories, 2019H-2029F (USD Million)
Figure 10: Global Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 11: Global Latent TB Testing Market Absolute Opportunity, By Hospitals and Clinics, 2019H-2029F (USD Million)
Figure 12: Global Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
Figure 13: Global Latent TB Testing Market Absolute Opportunity, By Academic and Research Institute, 2019H-2029F (USD Million)
Figure 14: Americas Latent TB Testing Market Size, By Value, 2019H-2029F (USD Million)
Figure 15: Americas Latent TB Testing Market Share, By Test Type, 2022 (%)
Figure 16: Americas Latent TB Testing Market , By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
Figure 17: Americas Latent TB Testing Market, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)
Figure 18: Americas Latent TB Testing Market , By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
Figure 19: Americas Latent TB Testing Market , By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 20: Americas Latent TB Testing Market , By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
Figure 21: United States Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 22: United States Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 23: United States Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 24: United States Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 25: Canada Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 26: Canada Latent TB Testing Market Value, By End User,, 2022 (USD Million)
Figure 27: Canada Latent TB Testing Market Value, By End User,, 2022 (USD Million)
Figure 28: Canada Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 29: Canada Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 30: Rest of Americas Latent TB Testing Market , By Value, 2019H-2029F (USD Million & CAGR)
Figure 31: Rest of Americas Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 32: Rest of Americas Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 33: Rest of Americas Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 34: Europe Latent TB Testing Market Size, By Value, 2019H-2029F (USD Million)
Figure 35: Europe Latent TB Testing Market Share, By Test Type, 2022 (%)
Figure 36: Europe Latent TB Testing Market , By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
Figure 37: Europe Latent TB Testing Market, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)
Figure 38: Europe Latent TB Testing Market , By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
Figure 39: Europe Latent TB Testing Market , By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 40: Europe Latent TB Testing Market , By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
Figure 41: Germany Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 42: Germany Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 43: Germany Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 44: Germany Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 45: United Kingdom Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 46: United Kingdom Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 47: United Kingdom Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 48: United Kingdom Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 49: France Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 50: France Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 51: France Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 52: France Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 53: Rest of Europe Latent TB Testing Market , By Value, 2019H-2029F (USD Million & CAGR)
Figure 54: Rest of Europe Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 55: Rest of Europe Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 56: Rest of Europe Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 57: Asia-Pacific Latent TB Testing Market Size, By Value, 2019H-2029F (USD Million)
Figure 58: Asia-Pacific Latent TB Testing Market Share, By Test Type, 2022 (%)
Figure 59: Asia-Pacific Latent TB Testing Market , By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
Figure 60: Asia-Pacific Latent TB Testing Market, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)
Figure 61: Asia-Pacific Latent TB Testing Market , By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
Figure 62: Asia-Pacific Latent TB Testing Market , By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 63: Asia-Pacific Latent TB Testing Market , By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
Figure 64: China Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 65: China Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 66: China Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 67: China Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 68: Japan Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 69: Japan Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 70: Japan Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 71: Japan Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 72: India Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 73: India Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 74: India Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 75: India Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 76: South Korea Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 77: South Korea Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 78: South Korea Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 79: South Korea Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 80: Australia Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 81: Australia Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 82: Australia Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 83: Australia Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 84: Rest of Asia-Pacific Latent TB Testing Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 85: Rest of Asia-Pacific Latent TB Testing Market Value, By End User, 2022 (USD Million)
Figure 86: Rest of Asia-Pacific Latent TB Testing Market Share, By Test Type, By Value, 2022 (%)
Figure 87: Rest of Asia-Pacific Latent TB Testing Market Share, By End User, By Value, 2022 (%)
Figure 88: Middle East and Africa Latent TB Testing Market Size, By Value, 2019H-2029F (USD Million)
Figure 89: Middle East and Africa Latent TB Testing Market Share, By Test Type, 2022 (%)
Figure 90: Middle East and Africa Latent TB Testing Market , By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)
Figure 91: Middle East and Africa Latent TB Testing Market, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)
Figure 92: Middle East and Africa Latent TB Testing Market , By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
Figure 93: Middle East and Africa Latent TB Testing Market , By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 94: Middle East and Africa Latent TB Testing Market , By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)
Figure 95: Global Impact of Drivers and Restraints
Figure 96: Market Share of Prominent Companies of Latent TB Testing Market, 2022 (%)
Figure 97: Qiagen Revenues, 2020-2022 (USD Million)
Figure 98: Qiagen Revenue , Product Sales by Disease Area, 2022 (%)
Figure 99: Qiagen Revenue , By Geographical Segments, 2022 (%)
Figure 100: Sanofi Revenues, 2020-2022 (USD Million)
Figure 101: Sanofi Revenues, By Geographic Segments, 2022 (%)
Figure 102: Sanofi Revenue , By Business Segments, 2022 (%)
Figure 103: Abbott Laboratories Revenues, 2020-2022 (USD Million)
Figure 104: Abbott Laboratories Revenues, By Geographic Segments, 2022 (%)
Figure 105: Abbott Laboratories Revenue , By Business Segments, 2022 (%)
Figure 106: Roche Revenues, 2020-2022 (USD Million)
Figure 107: Roche Revenue , By Business Segment, 2022 (%)
Figure 108: Bio-Rad Laboratories Revenues, 2020-2022 (USD Million)
Figure 109: Bio-Rad Laboratories Revenue , By Geographic segment, 2022 (%)
Figure 110: Bio-Rad Laboratories, By Business Segments, 2022 (%)
Figure 111: BioMerieux Revenues, 2020-2022 (USD Million)
Figure 112: BioMerieux Revenue , Product Sales By Business Segments, 2022 (%)
Figure 113: BioMerieux Revenue , By Geographical Segments, 2022 (%)
Figure 114: Becton Dickinson and Co Revenues, 2020-2022 (USD Million)
Figure 115: Becton Dickinson and Co Revenue , Product Sales By Business Segments, 2022 (%)
Figure 116: Becton Dickinson and Co Revenue , By Geographical Segments, 2022 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A3: United States Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A4: United States Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A5: United States Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A6: Canada Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A7: Canada Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A8: Canada Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A9: Canada Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A10: Rest of Americas Latent TB Testing Market , By Test Type, By Value, 2019-2022 (USD Million)
Table A11: Rest of Americas Latent TB Testing Market , By Test Type, By Value, 2023-2029 (USD Million)
Table A12: Rest of Americas Latent TB Testing Market , By End User, By Value, 2019-2022 (USD Million)
Table A13: Rest of Americas Latent TB Testing Market , By End User, By Value, 2023-2029 (USD Million)
Table A14: Germany Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A15: Germany Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A16: Germany Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A17: Germany Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A18: United Kingdom Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A19: United Kingdom Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A20: United Kingdom Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A21: United Kingdom Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A22: France Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A23: France Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A24: France Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A25: France Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A26: Rest of Europe Latent TB Testing Market , By Test Type, By Value, 2019-2022 (USD Million)
Table A27: Rest of Europe Latent TB Testing Market , By Test Type, By Value, 2023-2029 (USD Million)
Table A28: Rest of Europe Latent TB Testing Market , By End User, By Value, 2019-2022 (USD Million)
Table A29: Rest of Europe Latent TB Testing Market , By End User, By Value, 2023-2029 (USD Million)
Table A30: China Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A31: China Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A32: China Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A33: China Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A34: Japan Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A35: Japan Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A36: Japan Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A37: Japan Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A38: India Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A39: India Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A40: India Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A41: India Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A42: South Korea Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A43: South Korea Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A44: South Korea Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A45: South Korea Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A46: Australia Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A47: Australia Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A48: Australia Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A49: Australia Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A50: Rest of Asia-Pacific Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A51: Rest of Asia-Pacific Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A52: Rest of Asia-Pacific Latent TB Testing Market, By End User Industry, By Value, 2019-2022 (USD Million)
Table A53: Rest of Asia-Pacific Latent TB Testing Market, By End User Industry, By Value, 2023-2029 (USD Million)
Table A54: Qiagen Key Company Financials, 2020-2022
Table A55: Sanofi Key Financials, 2020-2022
Table A56: Abbott Laboratories Key Financials, 2020-2022
Table A57: Roche Key Financials, 2020-2022
Table A58: Bio-Rad Laboratories Key Company Financials, 2020-2022
Table A59: BioMerieux Key Company Financials, 2020-2022
Table A60: Becton Dickinson and Co Key Company Financials, 2020-2022

Companies Mentioned

  • QIAGEN
  • Sanofi
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories
  • BioMerieux
  • Becton Dickinson and Co
  • Serum Institute of India
  • PerkinElmer Inc.
  • LIONEX GmbH

Table Information

Report AttributeDetails
No. of Pages200
PublishedDecember 2023
Forecast Period2024 - 2029
Estimated Market Value ( USD ) in 2024 $ 2.23 Billion
Forecasted Market Value ( USD ) by 2029 $ 3.93 Billion
Compound Annual Growth Rate12.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living With HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029 - Product Image

Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living With HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029

  • Report
  • 261 Pages
  • Global
From
Latent TB Diagnostics Global Markets by Assay, by Risk Factor, and by Lab/Place. With Executive and Consultant Guides and Market Analysis and Forecasts 2023 - 2027 - Product Image

Latent TB Diagnostics Global Markets by Assay, by Risk Factor, and by Lab/Place. With Executive and Consultant Guides and Market Analysis and Forecasts 2023 - 2027

  • Report
  • 316 Pages
  • Global
From
Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand (QFT-Plus), Test Type, Application, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand (QFT-Plus), Test Type, Application, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Tuberculosis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Tuberculosis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 188 Pages
  • Global
From
Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By End Use (Diagnostic Laboratories, Hospitals & Clinics, and Others), By Type, By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By End Use (Diagnostic Laboratories, Hospitals & Clinics, and Others), By Type, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 226 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.